UNSPSC 51391744: Colterol

This classification denotes a beta-adrenergic agonist with the molecular formula C12H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1WH11068UO chemically known as 1,2-benzenediol, 4-(2-)((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (+/-)- but generally known as colterol, which bears US NIH Compound Identifier 25104. European Medicines Agency schedules Colterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06802MIG.

UNSPSC 51391744 Colterol is a Commodity code, but the recent state and local solicitation activity tagged under it does not align with pharmaceutical-grade colterol products. Seminole County, Florida released an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement appears designed to support community health and opioid-response initiatives rather than colterol specifically. Bidders must submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposal, maintain workers' compensation and general liability insurance, and comply with drug-free workplace and E-Verify requirements. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period; the county reserved the right to terminate with or without cause during that period.

The code shows limited recent relevant activity in state and local procurement. The single recorded opportunity is in Florida, and the sourcing body is a county government rather than a state agency, school district, transit authority, or other municipal entity. No other state or local jurisdictions have posted solicitations under this code in the recent period. The mismatch between the code's nominal scope and the Naloxone and drug-deactivation focus of the Seminole County bid suggests either a tagging error in the opportunity or that colterol procurement through state and local government channels is not active at present.